# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Dan Leonard maintains Certara (NASDAQ:CERT) with a Neutral and lowers the price target from $20 to $16.
Baird analyst Joe Vruwink maintains Certara (NASDAQ:CERT) with a Neutral and lowers the price target from $19 to $18.
Certara (NASDAQ:CERT) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.10 by 30...
Keybanc analyst Scott Schoenhaus maintains Certara (NASDAQ:CERT) with a Overweight and lowers the price target from $23 to $20.
JMP Securities analyst Constantine Davides reiterates Certara (NASDAQ:CERT) with a Market Perform.
Certara, excluding Chemaxon, is reiterating 2024 revenue, adjusted EBITDA margin, and adjusted diluted earnings per share guida...
The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing con...
Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the price target from $18 to $16.